Quantbot Technologies LP Albireo Pharma, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$18.01 - $23.78 $93,652 - $123,656	-5,200 Reduced 83.87%	1,000 $21,000
Q3 2022 Nov 07, 2022	BUY	$16.32 - $26.37 $98,817 - $159,670	6,055 Added 4175.86%	6,200 $120,000
Q2 2022 Aug 09, 2022	BUY	$18.54 - $37.29 $2,688 - $5,407	145 New	145 $2,000
Q4 2020 Feb 12, 2021	SELL	$31.56 - $42.16 $6,312 - $8,432	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $4,638 - $8,322	200 New	200 $6,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.